Towards interpretable prediction of recurrence risk in breast cancer using pathology foundation models

Jakub R. Kaczmarzyk, Sarah C. Van Alsten, Alyssa J. Cozzo +5

Transcriptomic assays such as the PAM50-based ROR-P score guide recurrence risk stratification in non-metastatic, ER-positive, HER2-negative breast cancer but are not universally a…